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The effects of the graft vs. host disease (GVH)  ~  on murine immune functions 
are currently under intensive study. A recent report (1) suggests that there is a 
heightened immune  responsiveness during  the  1st  wk  of the  GVH  reaction 
followed subsequently by  immunosuppression.  These time differences in  im- 
mune reactivity may explain, at least in part, earlier contradictory reports on 
the level of the antibody response (2, 3) and the effects on tumor growth (4-8) of 
GVH reactions. In addition, the late immunosuppression has been implicated in 
C-type RNA viral release and an increased incidence of lymphoreticular malig- 
nancies  (9).  The  relationship,  however,  among  chronic  immunostimulation, 
immunosuppression,  and  the  development  of lymphomas  remains  unclear. 
Moreover, the mechanism of immunosuppression is unknown. Virus particles, 
suppressor T cells, and macrophages have all been implicated (10-12).  Recently 
Phillips (13) has demonstrated a  suppressive substance released from thymic- 
dependent lymphocytes in the GVH reaction. This factor decreases the response 
of normal lymphocytes to mitogenic and allogeneic stimulation (1) and may be 
similar to previously reported soluble suppressors  released during allogeneic 
reactions (14). 
Previous work  in  this  laboratory has  demonstrated that  alpha-fetoprotein 
(AFP) binds to murine T  cells (15) and is a  potent inhibitor of certain murine 
cellular reactions (16), including cytotoxic reactions (17), as well as the antibody 
response to T-dependent antigens (18). We have demonstrated, moreover, that it 
may  function  as  a  serum  and  lymphocyte culture  supernatant  suppressive 
substance in a  group of patients with chronic active liver disease." In addition, 
our recent work has shown that AFP is synthesized by tissue mononuclear cells 
(lymph node and  spleen)  in  suppressed but  not nonsuppressed patients  with 
lymphoma  (19).  As  previous authors  have  suggested  a  relationship between 
lymphoma and murine GVH (11), the present study was undertaken to examine 
the role of AFP in murine GVH reactions. 
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Materials and Methods 
Animals.  C3H/HEJ and C3H x  C57BL/6FI (C3BF1) age-matched (6-wk old) mice were used in 
all in vivo experiments. CBA]J and BALB/c mice were used for in vitro mixed lymphocyte culture 
(MLC) reactions. All mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. 
Antisera.  The method of purification of mouse AFP and transferrin, and the preparation of 
monospecific antisera to these proteins have been described (18).  The antisera were shown to be 
monospecific by gel Ouchterlony immunediffusion and immunoelectrophoresis. Fluoresceination 
of antisera to AFP was performed as previously reported (15). 
In Vivo Allogeneic  Reactions  (GVH).  C3BF~  animals received 9  x  107 parental or syngeneic 
spleen cells (controls) on day 1 and were sacrificed at intervals of 3 days and 1, 4, and 8 wk. Before 
sacrifice,  the animals were  weighed and then exsanguinated under light anesthesia from the 
axillary  artery.  The  spleens  were  dissected,  the fat  removed,  and  the organs were  placed  in 
preweighed cold sterile Petri dishes and weighed on a Mettler Balance (Mettler Instrument Corp., 
Princeton, N.  J.).  Simonsen spleen body weight assays were calculated and figures  >1.3 were 
considered significant (20). Mesenteric and inguinal lymph nodes were dissected rapidly and both 
spleens and lymph nodes were transferred to sterile Petri dishes containing RPMI 1640  supple- 
mented with penicillin (10,000 U), streptomycin (1,000/~g) and L-glutamine (200 retool) (Grand 
Island Biological Co.,  Grand Island, N.  Y.).  The organs were individually forced through a  100 
mesh sterile screen with gentle pressure.  The suspensions were transferred to sterile test tubes 
(Falcon Plastics, Div. of BioQuest, Oxnard,  Calif.), pooled, washed three times in media, resus- 
pended in a convenient volume, and counted for use in in vitro experiments described below. The 
cells used to assess AFP and transferrin synthesis were washed two additional times in minimum 
essential media (MEM) lacking leucine (GIBCO), supplemented with penicillin and streptomycin. 
Viability, by trypan blue exclusion, was determined on all samples before and after the period of 
culture. 
In Vitro Synthesis.  The cells, diluted to 5 x  10  e viable mononuclear cells/ml, were cultured in 
microtiter plates (Cooke Laboratory Products Div., Dynatech Laboratories Inc., Alexandria, Va.) 
in 0.2 ml of MEM lacking leucine and supplemented with penicillin, streptomycin, glutamine, and 
21/2% heat-inactivated fetal calf serum (Microbiologic Associates, Bethesda, Md.). [~4C]leucine in a 
concentration of 0.4  ftCi  (sp act  >500 mCi/mmol)  (New England Nuclear,  Boston,  Mass.)  was 
added at the initiation of culture or at predetermined intervals for pulse experiments and the cells 
were  maintained at 37°C  in a  5% CO2  humidified atmosphere.  At 6-h intervals the cells were 
pooled by pipetting and the supernates, after centrifugation, were stored at -70°C. The cell button 
was suspended in Nonidet P-40 (NP-40) (Shell Chemical Co., New York) at room temperature for 
20 rain and the cells were lysed by mechanical mixing. The suspension was centrifuged at 105,000 g 
for 30 min (Beckman Spinco L 65; Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) and 
the liquid phase (cell sap) (21) removed by pipet. The button was resuspended in NP-40, allowed to 
remain for 2 h at room temperature and solubilized on a vortex mixer. All samples were dialyzed 
extensively against O. 14 M phosphate-buffered saline (PBS) and concentrated by Amicon filtration 
(Amicon Corp., Scientific Sys. Div., Lexington, Mass.) before precipitation with specific antisera. 
AFP and transferrin synthesis in the various fractions were determined as described below. It is 
possible that the short incubation with NP-40 used to obtain cell sap extracted some membrane 
proteins. However,  experiments in which cell sap and membranes were obtained by a  repeated 
freeze-thaw  technique did  not differ  significantly when  compared  with  the  method  described 
above. 
In Vitro Allogeneic Reactions  (MLC).  Two-way (bilateral) MLCs were performed according to 
a modification of the method of Peck and Bach (22). CBA/J and BALB/c spleen or lymph node cells, 
diluted to 2.5 × 10  ~ viable cells/ml with MEM-lacking leucine (synthesis) or RPMI 1640 (thymidine 
incorporation), were placed together in the presence of 21/2% fetal calf serum, previously shown to 
have minimal stimulatory activity. Control cultures contained each cell type alone. The cells were 
maintained at 37°C in a humidified 5% CO2 atmosphere for intervals of 1-96 h in the presence of 0.4 
~Ci of [~4C]leucine. In some experiments the cultures were not fed leucine but were pulsed 12 h 
before harvest with 1 ~tCi of [3H]thymidine. The cells were harvested and prepared as described for 
GVH cells or were harvested on an automatic-harvesting device (Skaytron, Norway) and counted 
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of triplicate samples of experimental divided by the sum of the mean of the controls. 
In Vitro Mitogen Reactivity.  C3BF~  spleen or lymph node cells from experimental or control 
animals were reacted with purified phytohemagglutinin (PHA) (The Wellcome Research Labora- 
tories,  Beckenham,  England)  using  three  different concentrations of PHA  in  a  microculture 
system previously described (16).  The arithmetic mean of triplicate samples using the optimum 
PHA concentration was determined and the results are expressed as counts per minute _+ standard 
error (SE) of the mean. Percent suppression was determined as 1 -  [(experimental)/(control)] x 
100. 
Quantitation of AFP and Transferrin Synthesis.  Samples from the GVH and MLC reactions 
were reacted with monospecific anti-AFP or antitransferrin antisera in the presence of mouse 
amniotic fluid  (MAF), which contains significant concentrations of both of these proteins.  The 
amount of MAF added was predetermined in quantitative precipitin reactions to yield a sufficient 
precipitate to work with and to be in antibody excess. The volumes were made equal with PBS and 
the samples incubated for 90 min at 37°C followed by incubation at 4°C for 18 h. The precipitates 
were washed three times in ice-cold PBS,  resuspended in 0.1  M  NaOH,  and aliquots added to 
scintillation vials with aquasol and counted on a liquid scintillation counter. Synthesis is reported 
as counts per minute and represents the activity of 1  x  106 viable mononuclear cells. 
Surface Fluorescence for AFP.  Routine staining for AFP  was  performed  as  previously de- 
scribed (15).  Briefly, 5  ×  106 cells were reacted with I00 ~l of specific antisera for 30 min at 4°C. 
The sample was washed three times with media,  placed on a  slide,  and sealed.  100 cells were 
counted  under  white  light and  the  percent  demonstrating  ring  fluorescence  under  UV  light 
recorded  (E.  Leitz,  Inc.,  Rockleigh,  N.  J.).  Previous blocking experiments  (15)  using purified 
mouse  AFP  and  cold  unlabeled  anti-AFP  antisera  demonstrated  the  monospecificity  of this 
reaction. Separate aliquots containing 5-10  ×  106 mononuclear cells were reacted with 0.5 ml of 
MAF (containing 1 mg/ml of AFP) as previously reported (15).  The samples were maintained at 
37°C for 90 rain, washed extensively with media, and reacted with antisera as reported above. 
Radioimmunoassay.  The double antibody technique was employed as described by G~eich et 
al.  (23).  Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis on 10% gels were done 
according to the method of Weber and Osborn (24),  and the gels were frozen, sectioned into 2-mm 
slices, dissolved in 0.1% SDS, then placed in aquasol, and counted. 
Results 
A  previous  report  (15)  has  shown  that  surface  AFP  is  not  detectable  by 
immunofluorescence  on normal  adult  murine spleen  or lymph node cells  and 
this was verified in the present study using both the C3H and C57BL strains. 
The results of experiments on cells from 8-wk GVH spleens are summarized in 
Table I and Fig.  1.  There is striking staining on the surface of spleen cells for 
AFP. 33% (average) of mononuclear cells demonstrate surface AFP. This could 
be increased  to almost half of the splenic cells  if the suspension was preincu- 
bated for 90 min with MAF as an exogenous source of AFP. Normal spleen cells 
treated similarly with MAF show 18-22% of the cells with surface AFP. Lymph 
node cells  from experimental  GVH animals showed only low numbers of cells 
with  surface  AFP  (0-6%).  When  lymph  node cells  are  incubated  with  MAF, 
however, a slightly higher percentage  (25-35%) bind AFP than do control non- 
GVH lymph node cells  (24-26%).  Controls consisted of C3BF~  --* C3BF, or C3H 
and C3BF,  alone,  and no staining for AFP was seen in either spleen or lymph 
nodes. 
The cells with surface AFP in the GVH spleens were both large,  immature- 
appearing  mononuclear cells  and  small,  well-differentiated  lymphocytes.  We 
cannot state what type of spleen cells (T, B, or macrophage) has surface AFP in 
the  GVH  reaction.  This  is  presently  being  investigated.  Experiments  with 
normal spleen and lymph node cells indicate that binding to the small lympho- ROBERT  H.  KELLER  AND  THOMAS  B.  TOMASI,  JR. 
TABLE  I 
Percentage of Cells Having Surface AFP by Immunofluorescence 
in Splenic and Lymph Node Cells of Animals Undergoing  an 8 
wk GVH Reaction 
Cells having 
Cells with sur-  bound AFP 
face AFP*  after incuba- 
tions 
%  % 
Control spleen  0  22-23 
Experimental spleen  28-38  42-45 
Control lymph node  0  24-26 
Experimental lymph node  0-6  25-35 
1143 
* Range for three  separate experiments with  10  experimental and  5 
control animals in each. 
$ Cells incubated in  MAF  (as a  source  of AFP) for 90  min  at  37°C, 
washed, and stained at 4°C with a fluoresceinated monospecific anti- 
AFP antiserum.  Ranges given for three separate experiments each 
including 10 experimental and 5 control animals. 
cyte populations is restricted to a  subset of T cells (15). In human lymphomas, 
however, T cells as well as unidentified large undifferentiated cells all bind AFP 
(2O). 
Since animals undergoing a GVH reaction have been reported to be immuno- 
suppressed (1), we examined the mitogenic response of spleen and lymph node 
cells from control  and  experimental  animals.  These  data  are  summarized  in 
Table II.  Spleen cells from 8-wk experimental  animals  stimulated by optimal 
concentrations  of PHA reveal  significant  suppression  (71%)  compared to con- 
trols.  Lymph  nodes  from  experimental  animals,  however,  were  normal  or 
showed slight augmentation  compared to the PHA response of controls. 
Since serum levels of AFP were similar in experimental (mean 500 ng/ml) and 
control animals  (565 ng/ml), we questioned whether AFP might be synthesized 
directly by splenic cells during allogeneic reactions. The results of these experi- 
ments are presented in Tables III and IV. There is striking synthesis of AFP by 
splenic cells in both the GVH and MLC reactions as measured by [~4C]leucine 
incorporation,  and  SDS gel electrophoresis revealed  ~4C incorporation  only in 
the band with a mol wt of 76,000,  which corresponds to the molecular weight of 
AFP by SDS gel analysis. In addition, supernates from MLC reactions in culture 
for 3 days were shown to have 1,000 ng/ml of AFP by radioimmunoassay,  while 
control cultures had <75 ng/ml.  No synthesis, however, is seen in controls (FI 
cells injected into F1) or in either control cell type in the MLC. The data shown in 
Table  IV  were obtained  using  a  two-way MLC  reaction,  but AFP synthesis, 
although less striking quantitatively,  could be shown using the one-way MLC 
reaction  in which the  BALB/c cells were pretreated  with mitomycin C  before 
culture. Transferrin synthesis, reported to occur in small amounts by stimulated 
mononuclear cells (25), was used as a control. The amount of synthetic activity, 
however,  was  markedly  less  than  that  of AFP  (GVH transferrin  supernate, 1144  ALPHA-FETOPROTEIN  IN  ALLOGENEIC  REACTIONS 
Fro.  1.  A photomicrograph of a  splenic lymphocyte from an 8 wk GVH reaction showing 
surface staining for AFP.  x  400. 
1,348-2,144;  sap,  2,942-3,700;  and  membrane,  444-728:  MLC supernate,  1,344- 
2,580;  sap, 352-2,528; and membrane,  212-1,196 cpm). In addition,  the curve of 
the magnitude of transferrin  synthesis at various time points (not shown) was 
different than AFP, with the major synthesis of transferrin  occurring earlier in 
the GVH and MLC reactions. These differences, as well as the demonstration of 
AFP synthesis both of [~4C]leucine  incorporation and radioimmunoassay,  show 
that AFP synthesis is marked (compared with transferrin) and specific in that it 
has different kinetics from transferrin. 
Since immunosuppression has been reported (1) to vary during the course of a 
GVH reaction,  we examined  AFP synthesis over several time periods.  These 
data are summarized in Table V and demonstrate that maximum AFP synthesis 
increases with the length of allogeneic stimulus for up to 60 days, despite similar 
indices  of GVH  reactivity  (Simonsen  assay,  1.45-1.49)  at  each  point  tested. 
Whether  this  relationship  exists  during  the  initial  7-day  period  when 
heightened immune reactivity has been noted (1) is under investigation. Prelim- 
inary data, however, show no surface AFP on 3-day GVH spleen cells and these 
cells demonstrate an increased response to PHA stimulation compared to control 
F~ animals. 
Another facet of these experiments  is presented in Figs.  2 and 3. There is a 
second peak of AFP counts in the membrane fractions in both the in vivo and in 
vitro allogeneic reactions  at  a  time  when  synthesis of AFP in the cell sap  is 
decreasing.  This pattern of reciprocal changes in membrane and sap AFP after 
the initial period of synthesis was observed in every experiment (eight GVH and 
four  MLC  reactions),  although  the  absolute  levels  of the  counts  varied.  In 
addition, the splenic MLC reaction revealed significant membrane AFP counts 
as summarized  in Table IV with  an  average  SI of 17  (range  15-19) while the ROBERT  H.  KELLER  AND  THOMAS  B.  TOMASI,  JR.  1145 
TABLE  II 
PHA Reactivity of Spleen and Lymph Node Mononuclear Cells from Animals 
Undergoing an 8 wk GVH Reaction 
Suppression of 
Unstimulated  Stimulated  experimental 
compared 
with control 
cpm  cpm  % 
Control spleen  4,665  -+ 32  150,649  -+  111  - 
Experimental spleen  247  -+  14  44,749  -  299  71 
Control lymph node  253  -+  73  68,671 
Experimental lymph node  937  -+ 337  87,007  0 
cpm represents arithmetic mean of triplicate samples with presence of optimum PHA concentra- 
tion (stimulated) or media alone (unstimulated). 
TABLE  III 
Synthesis of AFP by Splenic Mononuclear Cells from an 8 wk 
GVH Reaction 
GVH* 
Experimental spleen of  Control Spleen of 
C3H --* C3BF~  C3BFI  --* C3BF~ 
cpm*  cpm~ 
Supernate  4,480  162 
Sap  15,144  186 
Membrane  6,529  90 
* Figures are cpm as AFP (mean of 10 animals) after 48 h  of in vitro 
culture which was the time point showing maximum incorporation. 
$ Counts represent synthesis by 1 x  10  ~ viable spleen cells. 
lymph  node  MLC  reaction  showed negligible  membrane  AFP counts  with  a 
higher average SI of 50 (range 55-64). 
The increased MLC reaction of lymph node cells compared to spleen and the 
cyclic pattern of AFP synthesis in splenic cells suggested that membrane AFP 
might  act  as  a  regulator  of cell  mitotic  and/or  synthetic  activity with  high 
membrane AFP acting as a negative feedback signal. The results of the experi- 
ments pertinent to this possibility are summarized in Fig. 4. In each instance, 
when membrane  AFP increased,  protein synthesis, as measured by total TCA 
precipitable counts, diminished in the next 12 h and alternatively, when mem- 
brane AFP was present in small amounts, total protein synthesis subsequently 
increased. 
Discussion 
We have  demonstrated  that  splenic  mononuclear  cells obtained from  8-wk 
GVH  mice  have  surface-bound  AFP  and  that  the  spleens  of these  animals 
synthesize  significant  amounts  of AFP.  These  data  point  out the  important 
observation  that  nonhepatic  tissues  are  capable  of synthesizing  AFP  under 
appropriate stimulation. Although it seems likely that it is the splenic lymphoid 
cells that are synthesizing AFP, we have no direct proof of the cell type involved, 1146  ALPHA-FETOPROTEIN  IN  ALLOGENEIC  REACTIONS 
TABLE IV 
Synthesis of  AFP by Splenic and Lymph Node Mononuclear Cells 
from MLC Reactions 
Experimental 
Splenic MLC reac-  Lymph node MLC re- 
tions of CBA ---)  actions of CBA --* 
BALB/c  BALB/c 
cpm  cpm 
Supernate  6,264  4,128 
Sap  8,364  408 
Membrane  6,392  324 
Controls 
CBA  BALB/c  CBA  BALB/c 
alone  alone  alone  alone 
cpm  cpm  cpm  cpm 
Supernate  214  260  316  208 
Sap  24  30  68  164 
Membrane  121  171  148  228 
Figures are cpm as AFP(mean of four experiments) per 1 x  10" viable 
cells after 36 h of in vitro culture which was the time of initial maximum 
incorporation. The MLC was a  two-way reaction. Spleen SI,  17 (range 
15-19). Lymph node SI,  59 (range 55-64). 
and macrophages or other as yet unidentified cells may be synthesizing AFP. 
Tumor (lymphoma) cells could not be identified in the spleens of these animals. 
The  reports  (26,  27)  that  embryonic  antigens  appear  on the  surface  of cells 
undergoing blast transformation suggest that AFP may be produced by the cells 
undergoing activation in response to an allogeneic stimulus.  In the MLC reac- 
tion  the  AFP-synthesizing  cell  would  likely  be  the  responder  and  not  the 
mitomycin-treated  stimulator  cell,  although,  again,  we  have  not  ruled  out 
macrophages. 
The differences noted between the spleen and lymph node in the same GVH 
animals are of interest. Although the lymph node cells synthesized some AFP, 
there was no membrane-bound AFP by immunofluorescence and the levels of 
~4C-labeled  AFP in  the membrane  fractions of lymph node cells were signifi- 
cantly less than that in membranes of cells of splenic origin. This was not due to 
an absence of receptors for AFP on lymph node cells since both in this study and 
in our previous work (15) we have shown that incubation with AFP results in 
positive fluorescence in approximately 20% of the cells from both normal spleen 
and  lymph node.  It should be pointed out,  however, that  in the experiments 
where lymphoid cells are incubated with AFP, high concentrations  (1 mg/ml) 
are employed. The differences, therefore,  between the spleen and lymph node 
could be quantitative,  and using lower concentrations  of AFP may bring out 
differences in the binding properties between these cell types. This is of poten- 
tial  importance  in view of the reports  (28) of variations  in the distribution  of 
subpopulations of lymphocytes (amplifier vs. suppressor cells) in the lymph node ROBERT  H.  KELLER  AND  THOMAS  B.  TOMASI,  JR. 
TABLE  V 
Maximum AFP Synthesis as a Function of the Duration of the 
Allogeneic Stimulus in GVH 
Fraction*  7-Day GVH  30-Day  GVH  60-Day  GVH 
cpm  cpm  cpm 
Sap  7,512  10,696  15,144 
Membrane  1,144  4,756  6,529 
* Values  for  cpm  as AFP in  sap  and membrane fractions  obtained after 
48  h of  in  vitro  culture  which  was  the  time  of  maximum incorporation. 
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FIG.  2.  Time study of AFP synthesis in spleen cells from a  60  day GVH reaction. The 
method of separating sap and membrane fractions and determining AFP as counts per 
minute is described in the text. 
vs.  the  spleen.  Perhaps  these  subpopulations  have  different  affinities  and/or 
numbers of receptors per cell for AFP and, therefore, differential susceptibility 
to suppression by this protein. 
From reports in the literature  (29,  30) it appears that lymph node cells are 
significantly more reactive than spleen cells in MLC reactions.  The data sum- 
marized in Table IV support this and further suggest that these differences may 
be due to quantitative variations in the amount of membrane AFP. This possi- 
bility remains  speculative,  but  preliminary  data  employing  incubation  with 
graded  concentrations  of AFP reveal there  is significant  difference in  lymph 
node and spleen cells in their affinity for binding of AFP. 
When spleen and lymph node cells from GVH animals were preincubated with 
exogenous  AFP,  greater  numbers  of cells  showing  surface  AFP  were  found 1148  ALPHA-FETOPROTEIN  IN  ALLOGENEIC  REACTIONS 
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Fro.  3.  Timed study of AFP synthesis in spleen cells from a bilateral MLC reaction. The 
method of  separating sap and membrane  fractions  and determining  AFP counts  is described 
in the text. 
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FIG.  4.  GVH pulse experiments. ([]), counts per minute as AFP in membrane fraction of 
GVH spleen cells after 18, 48, or 72 h of incubation with ['4C]leucine added at initiation of 
culture. (D), counts per minute as TCA-precipitable protein in cell sap fractions of cultures 
pulsed with ['4C]leucine after 18, 48, and 72 h  of incubation and harvested 6 h  later.  (•), 
counts per minute as TCA-precipitable protein in cell sap fractions of cultures pulsed with 
['4C]leucine after 18, 48, and 72 h of incubation and harvested 12 h later. 
compared with similarly treated cells derived from normal animals. This was 
especially marked  with  spleens  from  GVH  animals  which  showed  approxi- 
mately twice the number of AFP-binding cells as control spleens. This could be 
due to a relative increase in GVH spleens of a special subset of  T cells that binds 
AFP.  It is  also possible that activated lymphocytes or macrophages have an 
increased number and/or affinity of receptors for AFP. In previous experiments 
(15) we have shown that "activated" peritoneal macrophages obtained using 
thioglycollate (31) do not bind AFP, although this does not rule out binding by 
macrophages activated during a  GVH reaction. 
Our work, like many other previous studies (reviewed in reference 11), has ROBERT  H,  KELLER  AND  THOMAS  B.  TOMASI,  JR.  1149 
shown immunosuppression during a  chronic GVH reaction.  Whether AFP is 
involved in the immunosuppression, however, is at present speculative. There 
are, nonetheless, a number of lines of indirect evidence which suggest that this 
is  a  reasonable possibility.  Firstly,  we have previously shown that  AFP is 
immunosuppressive  for certain T-mediated reactions as well as antibody synthe- 
sis in vitro when present in microgram amounts (0.1-1  /~g/ml) in the culture 
(17). Secondly, we have demonstrated that sera from pregnant mice and sera 
and supernates from lymphocyte cultures of patients with chronic hepatitis 
are immunosuppressive and that the immunosuppreasion is due to AFP (refer- 
ence 32, and footnote 2). Thirdly, in a group of 10 human lymphoma patients we 
have recently reported (19) the presence of tissue and circulating lymphocytes 
with surface AFP by immunofluorescence  and synthesis of AFP by splenic and 
lymph node tissues. These findings were restricted to those patients who were 
immunosuppressed and not to controls or nonsuppressed lymphoma patients, 
thus demonstrating a  significant correlation between AFP synthesis and im- 
mune suppression in lymphomas. This is particularly pertinent in view of the 
reported high  incidence of the  development of lymphomas in  animals  with 
chronic allogeneic disease (13). Finally, more direct evidence that AFP is the 
immunosuppressive factor in  supernates of mixed lymphocyte reactions has 
recently been  obtained  using  affinity chromatography to  specifically delete 
AFP.  Removal of AFP abolishes the suppressive properties of MLC  reaction 
supernates on the PHA and mixed lymphocyte response of normal cells2 
The binding and AFP synthesis by splenic and lymph node tissues in GVH 
reactions has implications in theories relating oncogenesis and immunity. In 
general, two theories have been proposed to explain the observed clinical and 
experimental association between immunity and malignancy. The theory of 
immune surveillance (33, 34) suggests that the immune system, particularly 
cell-mediated  immunity, is a primary mechanism in the natural defense against 
the development of malignant tumors. An alternate hypothesis has been pro- 
posed more recently  by several workers, particularly Prehn (35) and Meliefet al. 
(11). Advocates of this theory refute many of the tenets upon which immune 
surveillance is  based and  stress  the  high  incidence of malignancies of the 
lymphoid system in  both  immunosuppressed experimental animals and  pa- 
tients. Thus, there seems to be a special relationship btween immunosuppres- 
sion and lymphoproliferative diseases rather than among all types of malig- 
nancy. It has been suggested that impaired regulation of the immune response, 
especially if resulting in immunostimulation may be of primary importance in 
the development of tumors rather than deficient surveillance. Hirsch et al. (10) 
have reported that antigenic stimuli activate latent endogenous oncogenic C- 
type viruses, suggesting that oncogenic viruses replicate more readily in trans- 
formed, stimulated,  and/or deregulated cells.  On the clinical side,  the  high 
incidence of lymphomas in immunosuppressed patients may be related to the 
antigenic stimulus of the allograft or the autoimmurm disorder for which the 
3 Keller, R. H., and T. B. Tomasi. Alpha-fetoprotein:  a soluble inhibitor of  the immune response 
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patient  is being treated  with the  immunosuppressive agent.  In  addition,  the 
immunosuppressive agent itself, in an appropriate dosage, may selectively affect 
subpopulations of lymphocytes such as suppressor cells (36)and cause deregula- 
tion which in turn leads to proliferation and the appearance of onCornavirnses. 
Our data showing AFP synthesis in GVH reactions is consistent with either of 
these theories.  The allogeneic stimulus resulting in blast transformation  and 
synthesis of AFP could lead to defective tumor (surveillance)  and/or antiviral 
immunity.  No  data  is  currently  available  on  whether  AFP  activates  latent 
viruses. It is not unreasonable, however, that AFP could promote viral prolifer- 
ation since it inhibits both cell-mediated cytotoxicity (7) and antibody synthesis 
(18), both of which are known to be important in viral immunity. Further direct 
studies on the effect of AFP on viral infections are certainly indicated. 
We believe an important  aspect that is often neglected in discussions of the 
immune  system and  malignancy  concerns the  possibility of local  or regional 
immune suppression in the environment of the tumor.  For example, one of the 
points used to refute immune surveillance (37) is that animals and patients with 
early  spontaneously  arising  neoplasms  show  little  evidence of immune  defi- 
ciency. It is possible, nonetheless,  that the critical area to examine is not the 
systemic  antibody  or  cell-mediated  response  of circulating  lymphocytes  but 
rather the immune response in the local environment.  The production of small 
amounts of AFP by the tumor tissue itself or by lymphoid cells transformed in 
response to  tumor-specific  or  viral  antigens  may be sufficient to  inhibit  the 
destruction of the first few malignant  cells and allow them to gain  sufficient 
numbers to escape the subsequent immune response. The possibility of regional 
production  of AFP  not  reflected  systemically is  suggested  by the  finding  of 
splenic  AFP  synthesis  accompanied  by immune  suppression  with  normal  or 
decreased serum levels of AFP and no evidence of immune suppression in lymph 
nodes. This shows regional suppression even within lymphoid organs. 
The studies outlined in Figs. 2-4 demonstrate an inverse relationship between 
membrane-bound AFP and protein synthesis and suggest that AFP may have a 
more general  role  in  the  regulation  of cell synthetic  activities as a  negative 
feedback signal.  The  important  question  of whether  AFP  plays  any  role  in 
regulating normal adult lymphoid (or other) cells and their response to normally 
encountered antigens is presently under intensive study in our laboratory. 
Summary 
Surface-bound alpha-fetoprotein (AFP) was demonstrated by immunofluores- 
cence on approximately  1/3 of splenic lymphocytes in chronic murine graft vs. 
host  (GVH) reactions.  Splenic  lymphocytes were  also  shown  to  have  a  sup- 
pressed phytohemagglutinin  (PHA) response compared to controls while lymph 
node cells from the same GVH animals revealed no surface AFP and had normal 
PHA responses.  Splenic lymphocytes showed marked synthesis of AFP in the 
GVH and mixed lymphocyte culture (MLC) reactions by [14C]leucine incorpora- 
tion and by radioimmunoassay in MLC supernates. Lymph node cells, however, 
demonstrated less synthetic activity and ~4C counts in their membrane fractions 
were not markedly elevated. ROBERT  H.  KELLER  AND  THOMAS  B.  TOMASI,  JR.  1151 
The level of synthesis of AFP by spleen cells increased with the length of the 
allogeneic stimulus up to 8 wk. The pattern of AFP and total protein synthesis 
was shown to be cyclic. Pulse experiments with  [14C]leucine demonstrated that 
high  membrane  AFP  was associated with  a  marked decrease  in total protein 
synthesis  by  spleen  cells  in  the  next  12  h  while  low  membrane  AFP  was 
associated with marked protein synthesis.  This suggests that AFP could func- 
tion as a  negative feedback signal. These findings are discussed in relationship 
to the potential importance of allogeneic reactions and AFP in the interactions 
between the immune system and tumors. 
We gratefully  acknowledge the excellent  technical  assistance  of  Mrs. Mary Lou Iserson  and Mrs. 
Rita LeDuc. 
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